ACLA, AdvaMed Urge Congress to Immediately Replenish COVID-19 Testing Fund

The American Clinical Laboratory Association (ACLA) and AdvaMedDx, the medical device lobby’s division representing diagnostics makers, have joined with more than 60 organizations calling on congressional leaders to immediately replenish a fund that enabled uninsured people to access COVID-19 testing.

Citing insufficient funds, the COVID-19 Uninsured Relief Fund stopped accepting new claims for testing on March 22. ACLA, AdvaMedDx and the other signatories of the letter warn the funding expiration may put “the most vulnerable members” of communities at risk of losing resources to diagnose new COVID-19 infections.